Coverage of high-potential mid-market firms in Poland

Article

Neuca pharma posts PLN 13.1 mln net profit in Q4 vs. PLN 15.5 mln profit expected

TAG'S: NEUCA, Finance (other)

 

Listed pharmaceuticals distributor Neuca posted PLN 13.1 mln Q4 attributable net profit, below expectations for PLN 15.5 mln net take, Neuca said in FY 2013 report.

 

Q4 RESULTS VS CONSENSUS & VS YEAR-PRIOR PERIOD

 

  Q3 2013 consensus Q3 y/y vs Cons.
  PLN mln PLN mln % %
Revenues 1409,7 1464 -3,2 -3,7
Operating profit 17,1 18 -20,6 -5,2
Net attributable 13,1 15,5 -11,4 -15,3

2014-03-18



Comments : 0

Add comment

The published comments are private opinions of the users. Biznespolska Media Sp. z o.o. is not responsible for their content. Intelligent and insightful comments most appreciated.

Other News

Photo of the week

Photo of the week

Following an impressive run, PKN Orlen fuel reappoints CEO Wojciech Jasiński to spearhead the company to newer, more challenging waters. Gives him a new three year term!

2017-11-21

WSE Indices


NameValueChangeTime
WIG20 2468,32 +0,01 % 10:54
WIG 63596,36 -0,04 % 10:40
sWIG80 14039,26 +0,06 % 10:40
NCIndex 285,49 +0,08 % 10:40
2017-11-21

WSE Companies


Top 5 Gainers

NameValueChange
VISTULA GROUP3,97+8,47 %
DROZAPOL-PROFIL2,00+7,53 %
MEX POLSKA4,74+6,76 %
INTERFERIE3,60+6,82 %
BYTOM2,62+5,22 %

Top 5 Losers

NameValueChange
QUMAK1,29-7,86 %
INTER CARS264,80-6,10 %
IZOBLOK SPOLKA AKCYJNA103,20-5,32 %
SWISSMED CENTRUM ZDROWIA0,82-5,75 %
AWBUD SA4,50-4,05 %